FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Widening into Southeast Asia with Malaysian and Singaporean approvals for its stroke and dementia AI.

  • Stroke AI approved in Malaysia and dementia AI approved in Singapore. Source

Roles often seen at this stageData & AI · Regulatory affairs · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Heuron

A maker of AI medical devices that read brain images for stroke, dementia and other brain diseases, widening approvals in Southeast Asia.

Heuron StroCare Suite

Approved

AI software that supports stroke diagnosis from brain CT, approved in Malaysia.

Heuron AD

Approved

Dementia-analysis AI that quantifies brain atrophy from MRI, approved in Singapore.

Completion reported

Its stroke AI was approved in Malaysia and its dementia AI in Singapore.

Official role guide

Heuron careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 휴런, 말레이시아·싱가포르서 뇌 질환 AI 의료기기 허가 ↗간호사신문 · Published 2026-09-17 · Sources checked 2026-11-15
  2. 휴런, 말레이시아·싱가포르 인허가 연쇄 획득… 뇌신경질환 AI 아시아 벨트 확장 ↗한국데이터경제신문 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable